Skip to main content
Top
Published in: Obesity Surgery 4/2008

01-04-2008 | Research Article

The Effects of Liposuction Removal of Subcutaneous Abdominal Fat on Lipid Metabolism are Independent of Insulin Sensitivity in Normal-Overweight Individuals

Authors: J. Ybarra, F. Blanco-Vaca, S. Fernández, A. Castellví, R. Bonet, X. Palomer, J. Ordóñez-Llanos, A. Trius, R. Vila-Rovira, A. Pérez

Published in: Obesity Surgery | Issue 4/2008

Login to get access

Abstract

Background

Abdominal fat (both visceral and subcutaneous) accumulation is associated with an increased risk of developing insulin resistance. The latter stands as the basis upon which diabetes, hypertension, and atherogenic dyslipidemia tend to build up. Hence, abdominal liposuction (AL) could theoretically hold metabolic benefits. We undertook the present study to assess the effects of AL on carbohydrate and lipid metabolism.

Methods

This is a prospective study including 20 healthy volunteers (M2/F18) aged 39.6 ± 7.7 years old (24–52), body mass index (BMI) = 25.3 ± 4.7 kg/m2 (19.8–36) who underwent AL. Before and 4 months after AL, we measured glucose and insulin concentrations, HOMA index [glucose (mM) × IRI (μUI/l)/22.5], free fatty acids (FFA), glycerol, total cholesterol and triglycerides, high-density lipoprotein (HDL)-cholesterol (HDL-c), low-density lipoprotein (LDL)-cholesterol (LDL-c), very low-density lipoprotein (VLDL)-cholesterol (VLDL-c) and apolipoproteins (apo) B, AI and AII, adiponectin (Adp), and ultra-sensitive C-reactive protein (CRP).

Results

Lipo-aspirate averaged 5.494 ± 5.297 cc (600–19.000). Weight, BMI, and waist circumference decreased significantly 4 months after surgery by 4.6, 4.6 and 5.9%, respectively. There were significant decrements in FFA (−35%, p < 0.0001), glycerol (−63%, p < 0.0005), VLDL-c (−15.2%; p < 0.001), and triglycerides (−21.3%, p < 0.002), an increase in HDL-c (+10%, p < 0.03), Apo AI (+10.1%, p < 0.02), and Apo AII (+11.8%, p < 0.001). Total cholesterol, LDL-c, ApoB, and the LDL-c/ApoB ratio raised by +15% (p < 0.0005), +27.3% (p < 0.000), +15.1% (p < 0.008) and +2.76% (p < 0.008), respectively. Glucose, insulin, the HOMA index, Adp, and CRP were not significantly altered after AL.

Conclusion

AL in healthy normal weight or slightly overweight subjects improves the major lipoprotein components of obesity-associated dyslipidemia. This improvement occurs independent of insulin sensitivity.
Literature
1.
go back to reference Nieves DJ, Cnop M, Retzlaff B, Walden CE, Brunzell JD, Knopp RH, Kahn SE. The atherogenic lipoprotein profile associated with obesity and insulin resistance is largely attributable to intra-abdominal fat. Diabetes. 2003;52:172–9.PubMedCrossRef Nieves DJ, Cnop M, Retzlaff B, Walden CE, Brunzell JD, Knopp RH, Kahn SE. The atherogenic lipoprotein profile associated with obesity and insulin resistance is largely attributable to intra-abdominal fat. Diabetes. 2003;52:172–9.PubMedCrossRef
2.
go back to reference Taskinen MR. Diabetic dyslipidaemia: from basic research to clinical practice. Diabetologia. 2003;46:733–49.PubMedCrossRef Taskinen MR. Diabetic dyslipidaemia: from basic research to clinical practice. Diabetologia. 2003;46:733–49.PubMedCrossRef
3.
go back to reference Sparks JD, Sparks CE. Insulin regulation of triacylglycerol-rich lipoprotein synthesis and secretion. Biochem Biophys Acta. 1994;1215:9–32.PubMed Sparks JD, Sparks CE. Insulin regulation of triacylglycerol-rich lipoprotein synthesis and secretion. Biochem Biophys Acta. 1994;1215:9–32.PubMed
4.
go back to reference Lewis GF, Uffelman KD, Szeto LW, Weller B, Steiner G. Interaction between free fatty acids and insulin in the acute control of very low density lipoprotein production in humans. J Clin Invest. 1995;95:158–66.PubMedCrossRef Lewis GF, Uffelman KD, Szeto LW, Weller B, Steiner G. Interaction between free fatty acids and insulin in the acute control of very low density lipoprotein production in humans. J Clin Invest. 1995;95:158–66.PubMedCrossRef
5.
go back to reference Burnett JR, Barrett PH, Vicini P, Miller DB, Telford DE, Kleinstiver SJ, Huff MW. The HMG-CoA reductase inhibitor atorvastatin increases the fractional clearance rate of postprandial triglyceride-rich lipoproteins in miniature pigs. Arterioscler Thromb Vasc Biol. 1998;18:1906–14.PubMed Burnett JR, Barrett PH, Vicini P, Miller DB, Telford DE, Kleinstiver SJ, Huff MW. The HMG-CoA reductase inhibitor atorvastatin increases the fractional clearance rate of postprandial triglyceride-rich lipoproteins in miniature pigs. Arterioscler Thromb Vasc Biol. 1998;18:1906–14.PubMed
6.
go back to reference Hamsten A, Silveira A, Boquist S, Tang R, Bond MG, de Faire U, et al. The apolipoprotein CI content of triglyceride-rich lipoproteins independently predicts early atherosclerosis in healthy middle-aged men. J Am Coll Cardiol. 2005;45:1013–7.PubMedCrossRef Hamsten A, Silveira A, Boquist S, Tang R, Bond MG, de Faire U, et al. The apolipoprotein CI content of triglyceride-rich lipoproteins independently predicts early atherosclerosis in healthy middle-aged men. J Am Coll Cardiol. 2005;45:1013–7.PubMedCrossRef
7.
go back to reference Kissebah AH, Videlingum N, Murray R, Evans DJ, Hartz AJ, Kalkhoff RK, et al. Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab. 1982;54:254–60.PubMedCrossRef Kissebah AH, Videlingum N, Murray R, Evans DJ, Hartz AJ, Kalkhoff RK, et al. Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab. 1982;54:254–60.PubMedCrossRef
8.
go back to reference Cnop M, Landchild MJ, Vidal J, Havel PJ, Knowles NG, Carr DR, et al. The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations: distinct metabolic effects of two fat compartments. Diabetes. 2002;51:1005–15.PubMedCrossRef Cnop M, Landchild MJ, Vidal J, Havel PJ, Knowles NG, Carr DR, et al. The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations: distinct metabolic effects of two fat compartments. Diabetes. 2002;51:1005–15.PubMedCrossRef
9.
go back to reference Wajchenberg BL. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev. 2000;21:697–738.PubMedCrossRef Wajchenberg BL. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev. 2000;21:697–738.PubMedCrossRef
10.
go back to reference Freedland ES. Role of a critical visceral adipose tissue threshold (CVATT) in metabolic syndrome: implications for controlling dietary carbohydrates: a review. Nutr Metab (Lond). 2004;1:12.CrossRef Freedland ES. Role of a critical visceral adipose tissue threshold (CVATT) in metabolic syndrome: implications for controlling dietary carbohydrates: a review. Nutr Metab (Lond). 2004;1:12.CrossRef
11.
go back to reference Lambert EV, Hudson DA, Bloch CE, Koeslag JH. Metabolic response to localized surgical fat removal in nonobese women. Aesthet Plast Surg. 1991;15:105–10.CrossRef Lambert EV, Hudson DA, Bloch CE, Koeslag JH. Metabolic response to localized surgical fat removal in nonobese women. Aesthet Plast Surg. 1991;15:105–10.CrossRef
12.
go back to reference Carr DB, Utzschneider KM, Hull RL, Kodama K, Retzlaff BM, Brunzell JD, et al. Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes. 2004;53:2087–94.PubMedCrossRef Carr DB, Utzschneider KM, Hull RL, Kodama K, Retzlaff BM, Brunzell JD, et al. Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes. 2004;53:2087–94.PubMedCrossRef
13.
go back to reference Jensen MD, Johnson CM. Contribution of leg and splanchnic free fatty acid (FFA) kinetics to postabsorptive FFA flux in men and women. Metabolism. 1996;45:662–6.PubMedCrossRef Jensen MD, Johnson CM. Contribution of leg and splanchnic free fatty acid (FFA) kinetics to postabsorptive FFA flux in men and women. Metabolism. 1996;45:662–6.PubMedCrossRef
14.
go back to reference Abate N, Garg A, Peshock RM, Stray-Gundersen J, Grundy SM. Relationships of generalized and regional adiposity to insulin sensitivity in men. J Clin Invest. 1995;96:88–98.PubMedCrossRef Abate N, Garg A, Peshock RM, Stray-Gundersen J, Grundy SM. Relationships of generalized and regional adiposity to insulin sensitivity in men. J Clin Invest. 1995;96:88–98.PubMedCrossRef
15.
go back to reference Rendell M, Hulthen UL, Tornquist C, Groop L, Mattiasson I. Relationship between abdominal fat compartments and glucose and lipid metabolism in early postmenopausal women. J Clin Endocrinol Metab. 2001;86:744–9.PubMedCrossRef Rendell M, Hulthen UL, Tornquist C, Groop L, Mattiasson I. Relationship between abdominal fat compartments and glucose and lipid metabolism in early postmenopausal women. J Clin Endocrinol Metab. 2001;86:744–9.PubMedCrossRef
18.
go back to reference Klein S, Fontana L, Young VL, Coggan AR, Kilo C, Patterson BW, Mohammed BS. Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease. N Engl J Med. 2004;350:2549–57.PubMedCrossRef Klein S, Fontana L, Young VL, Coggan AR, Kilo C, Patterson BW, Mohammed BS. Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease. N Engl J Med. 2004;350:2549–57.PubMedCrossRef
19.
go back to reference Hong YG, Kim HT, Seo SW, Chang CH, Rhee EJ, Lee WY. Impact of large volume liposuction on serum lipids in Orientals: a pilot study. Aesthet Plast Surg. 2006;30:327–32.CrossRef Hong YG, Kim HT, Seo SW, Chang CH, Rhee EJ, Lee WY. Impact of large volume liposuction on serum lipids in Orientals: a pilot study. Aesthet Plast Surg. 2006;30:327–32.CrossRef
20.
go back to reference Lambert EV, Hudson DA, Bloch CE, Koeslag JH. Metabolic response to localized surgical fat removal in nonobese women. Aesthet Plast Surg. 1991;15:105–10.CrossRef Lambert EV, Hudson DA, Bloch CE, Koeslag JH. Metabolic response to localized surgical fat removal in nonobese women. Aesthet Plast Surg. 1991;15:105–10.CrossRef
21.
go back to reference Rizzo MR, Paolisso G, Grella R, Barbieri M, Grella E, Ragno E, et al. Is dermolipectomy effective in improving insulin action and lowering inflammatory markers in obese women? Clin Endocrinol (Oxf). 2005;63:253–8.CrossRef Rizzo MR, Paolisso G, Grella R, Barbieri M, Grella E, Ragno E, et al. Is dermolipectomy effective in improving insulin action and lowering inflammatory markers in obese women? Clin Endocrinol (Oxf). 2005;63:253–8.CrossRef
22.
go back to reference Gonzalez-Ortiz M, Robles-Cervantes JA, Cardenas-Camarena L, Bustos-Saldana R, Martinez-Abundis E. The effects of surgically removing subcutaneous fat on the metabolic profile and insulin sensitivity in obese women after large-volume liposuction treatment. Horm Metab Res. 2002;34:446–9.PubMedCrossRef Gonzalez-Ortiz M, Robles-Cervantes JA, Cardenas-Camarena L, Bustos-Saldana R, Martinez-Abundis E. The effects of surgically removing subcutaneous fat on the metabolic profile and insulin sensitivity in obese women after large-volume liposuction treatment. Horm Metab Res. 2002;34:446–9.PubMedCrossRef
23.
go back to reference Giese SY, Bulan EJ, Commons GW, Spear SL, Yanovski JA. Improvements in cardiovascular risk profile with large-volume liposuction: a pilot study. Plast Reconstr Surg. 2001;108:510–9.PubMedCrossRef Giese SY, Bulan EJ, Commons GW, Spear SL, Yanovski JA. Improvements in cardiovascular risk profile with large-volume liposuction: a pilot study. Plast Reconstr Surg. 2001;108:510–9.PubMedCrossRef
24.
go back to reference Samdal F, Birkeland KI, Ose L, Amland PF. Effect of large-volume liposuction on sex hormones and glucose- and lipid metabolism in females. Aesthet Plast Surg. 1995;19:131–5.CrossRef Samdal F, Birkeland KI, Ose L, Amland PF. Effect of large-volume liposuction on sex hormones and glucose- and lipid metabolism in females. Aesthet Plast Surg. 1995;19:131–5.CrossRef
25.
go back to reference Cazes L, Deitel M, Levine RH. Effect of abdominal lipectomy on lipid profile, glucose handling and blood pressure in patients with truncal obesity. Obes Surg. 1996;6:159–66.CrossRef Cazes L, Deitel M, Levine RH. Effect of abdominal lipectomy on lipid profile, glucose handling and blood pressure in patients with truncal obesity. Obes Surg. 1996;6:159–66.CrossRef
26.
go back to reference Giugliano G, Nicoletti G, Grella E, Giugliano F, Esposito K, Scuderi N, et al. Effect of liposuction on insulin resistance and vascular inflammatory markers in obese women. Br J Plast Surg. 2004;57:190–4.PubMedCrossRef Giugliano G, Nicoletti G, Grella E, Giugliano F, Esposito K, Scuderi N, et al. Effect of liposuction on insulin resistance and vascular inflammatory markers in obese women. Br J Plast Surg. 2004;57:190–4.PubMedCrossRef
27.
go back to reference Robles-Cervantes JA, Yanez-Diaz S, Cardenas-Camarena L. Modification of insulin, glucose and cholesterol levels in nonobese women undergoing liposuction: is liposuction metabolically safe? Ann Plast Surg. 2004;52:64–7.PubMedCrossRef Robles-Cervantes JA, Yanez-Diaz S, Cardenas-Camarena L. Modification of insulin, glucose and cholesterol levels in nonobese women undergoing liposuction: is liposuction metabolically safe? Ann Plast Surg. 2004;52:64–7.PubMedCrossRef
28.
go back to reference Commons GW, Halperin B, Chang CC. Large-volume liposuction: a review of 631 consecutive cases over 12 years. Plast Reconstr Surg. 2001;108:1753–63.PubMedCrossRef Commons GW, Halperin B, Chang CC. Large-volume liposuction: a review of 631 consecutive cases over 12 years. Plast Reconstr Surg. 2001;108:1753–63.PubMedCrossRef
29.
go back to reference Lambert EV, Hudson DA, Bloch CE, Koeslag JH. Metabolic response to localized surgical fat removal in nonobese women. Aesthet Plast Surg. 1991;15:105–10.CrossRef Lambert EV, Hudson DA, Bloch CE, Koeslag JH. Metabolic response to localized surgical fat removal in nonobese women. Aesthet Plast Surg. 1991;15:105–10.CrossRef
30.
go back to reference Vandeweyer E. Does liposuction influence lipidogram in females: in vivo study. Aesthet Plast Surg. 2002;26:17–9. Vandeweyer E. Does liposuction influence lipidogram in females: in vivo study. Aesthet Plast Surg. 2002;26:17–9.
31.
go back to reference Friedewald WT, Levy RJ, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without the use of the preparative ultracentrifuge. Clin Chem. 1972;18:499–502.PubMed Friedewald WT, Levy RJ, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without the use of the preparative ultracentrifuge. Clin Chem. 1972;18:499–502.PubMed
32.
33.
go back to reference Busetto L. Visceral obesity and the metabolic syndrome: effects of weight loss. Nutr Metab Cardiovasc Dis. 2004;11:195–204. Busetto L. Visceral obesity and the metabolic syndrome: effects of weight loss. Nutr Metab Cardiovasc Dis. 2004;11:195–204.
34.
go back to reference Goodpaster BH, Kelley DE, Wing RR, Meier A, Thaete FL. Effects of weight loss on regional fat distribution and insulin sensitivity in obesity. Diabetes. 1999;48:839–47.PubMedCrossRef Goodpaster BH, Kelley DE, Wing RR, Meier A, Thaete FL. Effects of weight loss on regional fat distribution and insulin sensitivity in obesity. Diabetes. 1999;48:839–47.PubMedCrossRef
35.
go back to reference Purnell JQ, Kahn SE, Albers JJ, Nevin DN, Brunzell JD, Schwartz RS. Effect of weight loss with reduction of intra-abdominal fat on lipid metabolism in older men. J Clin Endocrinol Metab. 2000;85:977–82.PubMedCrossRef Purnell JQ, Kahn SE, Albers JJ, Nevin DN, Brunzell JD, Schwartz RS. Effect of weight loss with reduction of intra-abdominal fat on lipid metabolism in older men. J Clin Endocrinol Metab. 2000;85:977–82.PubMedCrossRef
36.
go back to reference Thorne A, Lonnqvist F, Apelman J, Hellers G, Arner P. A pilot study of longterm effects of a novel obesity treatment: omentectomy in connection with adjustable gastric banding. Int J Obes Relat Metab Disord. 2002;26:193–9.PubMedCrossRef Thorne A, Lonnqvist F, Apelman J, Hellers G, Arner P. A pilot study of longterm effects of a novel obesity treatment: omentectomy in connection with adjustable gastric banding. Int J Obes Relat Metab Disord. 2002;26:193–9.PubMedCrossRef
37.
go back to reference Klein S, Luu K, Gasic S, Green A. Effect of weight loss on whole body and cellular lipid metabolism in severely obese humans. Am J Physiol. 1996;270:E739–E745.PubMed Klein S, Luu K, Gasic S, Green A. Effect of weight loss on whole body and cellular lipid metabolism in severely obese humans. Am J Physiol. 1996;270:E739–E745.PubMed
38.
go back to reference Knittle JL, Ginsberg-Fellner F. Effect of weight reduction on in vitro adipose tissue lipolysis and cellularity in obese adolescents and adults. Diabetes. 1972;21:754–61.PubMed Knittle JL, Ginsberg-Fellner F. Effect of weight reduction on in vitro adipose tissue lipolysis and cellularity in obese adolescents and adults. Diabetes. 1972;21:754–61.PubMed
39.
go back to reference Barzilai N, She L, Liu BQ, Vuguin P, Cohen P, Wang J, et al. Surgical removal of visceral fat reverses hepatic insulin resistance. Diabetes. 1999;48:94–8.PubMedCrossRef Barzilai N, She L, Liu BQ, Vuguin P, Cohen P, Wang J, et al. Surgical removal of visceral fat reverses hepatic insulin resistance. Diabetes. 1999;48:94–8.PubMedCrossRef
40.
go back to reference Gabriela I, Ma XH, Yang XM, Atzmon G, Rajala MW, Berg AH, et al. Removal of visceral fat prevents insulin resistance and glucose intolerance of aging: an adipokine-mediated process? Diabetes. 2002;51:2951–8.CrossRef Gabriela I, Ma XH, Yang XM, Atzmon G, Rajala MW, Berg AH, et al. Removal of visceral fat prevents insulin resistance and glucose intolerance of aging: an adipokine-mediated process? Diabetes. 2002;51:2951–8.CrossRef
41.
go back to reference Matarasso A, Kim RW, Kral JG. The impact of liposuction on body fat. Plast Reconstr Surg. 1998;102:1686–9.PubMedCrossRef Matarasso A, Kim RW, Kral JG. The impact of liposuction on body fat. Plast Reconstr Surg. 1998;102:1686–9.PubMedCrossRef
42.
go back to reference Dandona P, Weinstock R, Thusu K, Abdel-Rahman E, Aljada A, Wadden T. Tumor necrosis factor-alpha in sera of obese patients: fall with weight loss. J Metab. 1998;83:2907–10. Dandona P, Weinstock R, Thusu K, Abdel-Rahman E, Aljada A, Wadden T. Tumor necrosis factor-alpha in sera of obese patients: fall with weight loss. J Metab. 1998;83:2907–10.
43.
go back to reference Goodpaster BH, Theriault R, Watkins SC, Kelley DE. Intramuscular lipid content is increased in obesity and decreased by weight loss. Metabolism. 2000;49:467–72.PubMedCrossRef Goodpaster BH, Theriault R, Watkins SC, Kelley DE. Intramuscular lipid content is increased in obesity and decreased by weight loss. Metabolism. 2000;49:467–72.PubMedCrossRef
44.
go back to reference Yang WS, Lee WJ, Funahashi T, Tanaka S, Matsuzawa Y, Chao CL, et al. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab. 2001;86:3815–9.PubMedCrossRef Yang WS, Lee WJ, Funahashi T, Tanaka S, Matsuzawa Y, Chao CL, et al. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab. 2001;86:3815–9.PubMedCrossRef
45.
go back to reference Dattilo AM, Kris-Etherton PM. Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis. Am J Clin Nutr. 1992;56:320–8.PubMed Dattilo AM, Kris-Etherton PM. Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis. Am J Clin Nutr. 1992;56:320–8.PubMed
46.
go back to reference Lewis GF. Fatty acid regulation of very low density lipoprotein production. Curr Opin Lipidol. 1997;8:146–56.PubMedCrossRef Lewis GF. Fatty acid regulation of very low density lipoprotein production. Curr Opin Lipidol. 1997;8:146–56.PubMedCrossRef
47.
go back to reference Fruchart JC, Duriez P. Mode of action of fibrates in the regulation of triglyceride and HDL-cholesterol metabolism. Drugs Today (Barc). 2006;42:39–64. Fruchart JC, Duriez P. Mode of action of fibrates in the regulation of triglyceride and HDL-cholesterol metabolism. Drugs Today (Barc). 2006;42:39–64.
48.
go back to reference Goldberg RB, Kendall DM, Deeg MA, Buse JB, Zagar AJ, Pinaire JA, et al. A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemia. Diabetes Care. 2005;28:1547–54.PubMedCrossRef Goldberg RB, Kendall DM, Deeg MA, Buse JB, Zagar AJ, Pinaire JA, et al. A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemia. Diabetes Care. 2005;28:1547–54.PubMedCrossRef
49.
go back to reference Mittendorfer B, Patterson BW, Klein S. Effect of weight loss on VLDL triglyceride and ApoB-100 kinetics in women with abdominal obesity. Am J Physiol Endocrinol Metab. 2003;284:549–56. Mittendorfer B, Patterson BW, Klein S. Effect of weight loss on VLDL triglyceride and ApoB-100 kinetics in women with abdominal obesity. Am J Physiol Endocrinol Metab. 2003;284:549–56.
50.
go back to reference Melish J, Le NA, Ginsberg H, Steinberg D, Brown WV. Dissociation of Apoprotein B and triglyceride production in very low-density lipoproteins. Am J Physiol Endocrinol Metab. 1980;239:E354–62. Melish J, Le NA, Ginsberg H, Steinberg D, Brown WV. Dissociation of Apoprotein B and triglyceride production in very low-density lipoproteins. Am J Physiol Endocrinol Metab. 1980;239:E354–62.
51.
go back to reference Superko HR, McGovern ME, Raul E, Garrett B. Nicotinic acid has a significantly greater effect on the decrease of small LDL subclass distribution and increase in LDL peak particle diameter in pattern B versus pattern A. Differential effect of two nicotinic acid preparations on low-density lipoprotein subclass distribution in patients classified as low-density lipoprotein pattern A, B or I. Am J Cardiol. 2004;94:588–94.PubMedCrossRef Superko HR, McGovern ME, Raul E, Garrett B. Nicotinic acid has a significantly greater effect on the decrease of small LDL subclass distribution and increase in LDL peak particle diameter in pattern B versus pattern A. Differential effect of two nicotinic acid preparations on low-density lipoprotein subclass distribution in patients classified as low-density lipoprotein pattern A, B or I. Am J Cardiol. 2004;94:588–94.PubMedCrossRef
52.
go back to reference Superko HR, Berneis KK, Williams PT, Rizzo M, Wood PD. Gemfibrozil reduces small low-density lipoprotein more in normolipemic subjects classified as low density lipoprotein pattern B compared with pattern A. Am J Cardiol. 2005;96:1266–72.PubMedCrossRef Superko HR, Berneis KK, Williams PT, Rizzo M, Wood PD. Gemfibrozil reduces small low-density lipoprotein more in normolipemic subjects classified as low density lipoprotein pattern B compared with pattern A. Am J Cardiol. 2005;96:1266–72.PubMedCrossRef
Metadata
Title
The Effects of Liposuction Removal of Subcutaneous Abdominal Fat on Lipid Metabolism are Independent of Insulin Sensitivity in Normal-Overweight Individuals
Authors
J. Ybarra
F. Blanco-Vaca
S. Fernández
A. Castellví
R. Bonet
X. Palomer
J. Ordóñez-Llanos
A. Trius
R. Vila-Rovira
A. Pérez
Publication date
01-04-2008
Publisher
Springer-Verlag
Published in
Obesity Surgery / Issue 4/2008
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-007-9261-5

Other articles of this Issue 4/2008

Obesity Surgery 4/2008 Go to the issue